Neuroprotective Effect of Caffeine in Alzheimer’s Disease
Alzheimer’s disease (AD) is the leading cause of dementia, predicted to be the most significant health burden of the 21st century, with an estimated 131.5 million dementia patients by the year 2050. This review aims to provide an overview of the effect of caffeine on AD and cognition by summarizing...
Main Authors: | Y Mukish M Yelanchezian, Henry J. Waldvogel, Richard L. M. Faull, Andrea Kwakowsky |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/12/3737 |
Similar Items
-
Drinking coffee may reduce chances of developing Alzheimer’s disease: systematic literature review and meta-analysis
by: Sheba R. David, et al.
Published: (2022-10-01) -
Coffee and Alzheimer's Disease: Reviewing the Neuroprotective Effects of Bioactive Compounds
by: Katarzyna Madyniak, et al.
Published: (2024-10-01) -
Caffeine, coffee, and health /
by: Garattini, Silvio
Published: (1993) -
Impact of Caffeine on Alzheimer’s Disease Pathogenesis—Protective or Risk Factor?
by: Thomas Gabriel Schreiner, et al.
Published: (2022-02-01) -
Caffeine-induced hypokalemia: a case report
by: Min Jee Han, et al.
Published: (2021-07-01)